Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1270

1.

[Apolipoprotein A-I and B in laboratory diagnostics of dyslipidemia--what benefits do we gain compared with cholesterol measurements?].

Leiviskä J, Sundvall J, Jauhiainen M, Laatikainen T.

Duodecim. 2014;130(22-23):2331-7. Finnish.

PMID:
25558595
3.

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.

Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Rorick T, Sasiela WJ, Shirodaria C, Szarek M, Tamby JF, Tricoci P, White H, Zeiher A, Steg PG.

Am Heart J. 2014 Nov;168(5):682-9. doi: 10.1016/j.ahj.2014.07.028. Epub 2014 Aug 7.

4.

Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.

Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2465-72. doi: 10.1161/ATVBAHA.114.303932. Epub 2014 Sep 11.

PMID:
25212234
5.
6.

Serum lipids, apolipoproteins, and mortality among coronary artery disease patients.

Ding D, Li X, Qiu J, Li R, Zhang Y, Su D, Li Z, Wang M, Lv X, Wang D, Yang Y, Xia M, Li D, Hu G, Ling W.

Biomed Res Int. 2014;2014:709756. doi: 10.1155/2014/709756. Epub 2014 May 29.

7.

The role of exercise training on lipoprotein profiles in adolescent males.

Koozehchian MS, Nazem F, Kreider RB, Roberts WJ, Best TM, Rong Y, Zuo L.

Lipids Health Dis. 2014 Jun 9;13:95. doi: 10.1186/1476-511X-13-95.

8.

Subclinical atherosclerosis determinants in morbid obesity.

Megias-Rangil I, Merino J, Ferré R, Plana N, Heras M, Cabré A, Bonada A, Rabassa A, Masana L.

Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):963-8. doi: 10.1016/j.numecd.2014.04.012. Epub 2014 May 6.

PMID:
24907020
9.

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.

Farnier M, Chen E, Johnson-Levonas AO, McCrary Sisk C, Mitchel YB.

Vasc Health Risk Manag. 2014 May 7;10:279-90. doi: 10.2147/VHRM.S58694. eCollection 2014.

10.

Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.

Corsetti JP, Gansevoort RT, Bakker SJ, Sparks CE, Vart P, Dullaart RP.

J Am Soc Nephrol. 2014 Dec;25(12):2906-15. doi: 10.1681/ASN.2013121256. Epub 2014 May 22.

PMID:
24854276
11.

Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension.

Baszczuk A, Musialik K, Kopczyński J, Thielemann A, Kopczyński Z, Kęsy L, Dopierała G.

Adv Med Sci. 2014 Mar;59(1):68-73. doi: 10.1016/j.advms.2013.08.001. Epub 2014 Mar 20.

PMID:
24797978
12.

Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.

Rinne P, Silvola JM, Hellberg S, Ståhle M, Liljenbäck H, Salomäki H, Koskinen E, Nuutinen S, Saukko P, Knuuti J, Saraste A, Roivainen A, Savontaus E.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1346-54. doi: 10.1161/ATVBAHA.113.302963. Epub 2014 May 1.

PMID:
24790139
13.

High-density lipoproteins: taking the good with the bad.

Sparks CE, Corsetti JP, Sparks JD.

Curr Opin Lipidol. 2014 Jun;25(3):230-2. doi: 10.1097/MOL.0000000000000079. No abstract available.

PMID:
24763089
14.

Hypobetalipoproteinemia and abetalipoproteinemia.

Welty FK.

Curr Opin Lipidol. 2014 Jun;25(3):161-8. doi: 10.1097/MOL.0000000000000072. Review.

PMID:
24751931
15.

Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials.

Thanassoulis G, Williams K, Ye K, Brook R, Couture P, Lawler PR, de Graaf J, Furberg CD, Sniderman A.

J Am Heart Assoc. 2014 Apr 14;3(2):e000759. doi: 10.1161/JAHA.113.000759.

16.

Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis.

Vuorio T, Nurmi H, Moulton K, Kurkipuro J, Robciuc MR, Ohman M, Heinonen SE, Samaranayake H, Heikura T, Alitalo K, Ylä-Herttuala S.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1162-70. doi: 10.1161/ATVBAHA.114.302528. Epub 2014 Apr 10.

PMID:
24723556
17.

Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.

Nishikura T, Koba S, Yokota Y, Hirano T, Tsunoda F, Shoji M, Hamazaki Y, Suzuki H, Itoh Y, Katagiri T, Kobayashi Y.

J Atheroscler Thromb. 2014;21(8):755-67. Epub 2014 Apr 8.

18.

What is new in familial hypercholesterolemia?

Santos RD, Maranhao RC.

Curr Opin Lipidol. 2014 Jun;25(3):183-8. doi: 10.1097/MOL.0000000000000073. Review.

PMID:
24699416
19.

Cardiometabolic implications of postpartum weight changes in the first year after delivery.

Kew S, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

Diabetes Care. 2014 Jul;37(7):1998-2006. doi: 10.2337/dc14-0087. Epub 2014 Mar 25.

PMID:
24667457
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk